{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T13:15:41Z","timestamp":1792761341019,"version":"4.5.0"},"reference-count":136,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T00:00:00Z","timestamp":1647907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Patients with chronic kidney disease (CKD) are more prone to oxidative stress and chronic inflammation, which may lead to an increase in the synthesis of advanced glycation end products (AGEs). Because AGEs are mostly removed by healthy kidneys, AGE accumulation is a result of both increased production and decreased kidney clearance. On the other hand, AGEs may potentially hasten decreasing kidney function in CKD patients, and are independently related to all-cause mortality. They are one of the non-traditional risk factors that play a significant role in the underlying processes that lead to excessive cardiovascular disease in CKD patients. When AGEs interact with their cell-bound receptor (RAGE), cell dysfunction is initiated by activating nuclear factor kappa-B (NF-\u03baB), increasing the production and release of inflammatory cytokines. Alterations in the AGE-RAGE system have been related to the development of several chronic kidney diseases. Soluble RAGE (sRAGE) is a decoy receptor that suppresses membrane-bound RAGE activation and AGE-RAGE-related toxicity. sRAGE, and more specifically, the AGE\/sRAGE ratio, may be promising tools for predicting the prognosis of kidney diseases. In the present review, we discuss the potential role of AGEs and sRAGE as biomarkers in different kidney pathologies.<\/jats:p>","DOI":"10.3390\/ijms23073439","type":"journal-article","created":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T14:55:35Z","timestamp":1647960935000},"page":"3439","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":74,"title":["The Role of Advanced Glycation End Products and Its Soluble Receptor in Kidney Diseases"],"prefix":"10.3390","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2731-7545","authenticated-orcid":false,"given":"Mieke","family":"Steenbeke","sequence":"first","affiliation":[{"name":"Nephrology Unit, Department of Internal Medicine and Pediatrics, Ghent University Hospital, 9000 Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhart","family":"Speeckaert","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Ghent University Hospital, 9000 Ghent, Belgium"},{"name":"Research Foundation Flanders, 1000 Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6846-6558","authenticated-orcid":false,"given":"St\u00e9phanie","family":"Desmedt","sequence":"additional","affiliation":[{"name":"Nephrology Unit, Department of Internal Medicine and Pediatrics, Ghent University Hospital, 9000 Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7641-4707","authenticated-orcid":false,"given":"Griet","family":"Glorieux","sequence":"additional","affiliation":[{"name":"Nephrology Unit, Department of Internal Medicine and Pediatrics, Ghent University Hospital, 9000 Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5702-6792","authenticated-orcid":false,"given":"Joris R.","family":"Delanghe","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Sciences, Ghent University, 9000 Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9183-4390","authenticated-orcid":false,"given":"Marijn M.","family":"Speeckaert","sequence":"additional","affiliation":[{"name":"Nephrology Unit, Department of Internal Medicine and Pediatrics, Ghent University Hospital, 9000 Ghent, Belgium"},{"name":"Research Foundation Flanders, 1000 Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,3,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.kint.2017.11.034","article-title":"Advanced glycation end products in the pathogenesis of chronic kidney disease","volume":"93","author":"Rabbani","year":"2018","journal-title":"Kidney Int."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1681\/ASN.2014101047","article-title":"Uremic Toxicity of Advanced Glycation End Products in CKD","volume":"27","author":"Stinghen","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/10715762.2013.815348","article-title":"Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): An overview of their mechanisms of formation","volume":"47","author":"Vistoli","year":"2013","journal-title":"Free Radic. Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1007\/s00726-021-03091-8","article-title":"Urinary excretion of amino acids and their advanced glycation end-products (AGEs) in adult kidney transplant recipients with emphasis on lysine: Furosine excretion is associated with cardiovascular and all-cause mortality","volume":"53","author":"Baskal","year":"2021","journal-title":"Amino Acids"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0021-9150(99)00038-6","article-title":"N\u03b5-(carboxymethyl)lysine in atherosclerotic vascular lesions as a marker for local oxidative stress","volume":"144","author":"Nerlich","year":"1999","journal-title":"Atherosclerosis"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"dc212196","DOI":"10.2337\/dc21-2196","article-title":"Advanced Glycation End Products Predict Loss of Renal Function and High-Risk Chronic Kidney Disease in Type 2 Diabetes","volume":"45","author":"Koska","year":"2022","journal-title":"Diabetes Care"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s11892-013-0371-2","article-title":"Hyperglycemia and Vascular Metabolic Memory: Truth or Fiction?","volume":"13","author":"Bianchi","year":"2013","journal-title":"Curr. Diabetes Rep."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1007\/s00125-021-05539-8","article-title":"The legacy effect in diabetes: Are there long-term benefits?","volume":"64","author":"Folz","year":"2021","journal-title":"Diabetologia"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Molinari, P., Caldiroli, L., Dozio, E., Rigolini, R., Giubbilini, P., Romanelli, M.M.C., Messa, P., and Vettoretti, S. (2021). AGEs and sRAGE Variations at Different Timepoints in Patients with Chronic Kidney Disease. Antioxidants, 10.","DOI":"10.3390\/antiox10121994"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Dozio, E., Vettoretti, S., Caldiroli, L., Nerini-Molteni, S., Tacchini, L., Ambrogi, F., Messa, P., and Corsi Romanelli, M.M. (2020). Advanced Glycation End Products (AGE) and Soluble Forms of AGE Receptor: Emerging Role as Mortality Risk Factors in CKD. Biomedicines, 8.","DOI":"10.3390\/biomedicines8120638"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1347432","DOI":"10.1155\/2018\/1347432","article-title":"Role of the Soluble Receptor for Advanced Glycation End Products (sRAGE) as a Prognostic Factor for Mortality in Hemodialysis and Peritoneal Dialysis Patients","volume":"2018","author":"Dozio","year":"2018","journal-title":"Mediat. Inflamm."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1210\/jc.2007-1817","article-title":"The Role of Advanced Glycation End Products in Progression and Complications of Diabetes","volume":"93","author":"Goh","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Gryszczy\u0144ska, B., Budzy\u0144, M., Begier-Krasi\u0144ska, B., Osi\u0144ska, A., Boruczkowski, M., Kaczmarek, M., Bukowska, A., Iskra, M., and Kasprzak, M.P. (2019). Association between Advanced Glycation End Products, Soluble RAGE Receptor, and Endothelium Dysfunction, Evaluated by Circulating Endothelial Cells and Endothelial Progenitor Cells in Patients with Mild and Resistant Hypertension. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20163942"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1196\/annals.1333.052","article-title":"Diet-Derived Advanced Glycation End Products Are Major Contributors to the Body\u2019s AGE Pool and Induce Inflammation in Healthy Subjects","volume":"1043","author":"Uribarri","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Salazar, J., Navarro, C., Ortega, \u00c1., Nava, M., Morillo, D., Torres, W., Hern\u00e1ndez, M., Cabrera, M., Angarita, L., and Ortiz, R. (2021). Advanced Glycation End Products: New Clinical and Molecular Perspectives. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph18147236"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"9889","DOI":"10.1016\/S0021-9258(17)36966-1","article-title":"Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors\/binding proteins","volume":"269","author":"Yan","year":"1994","journal-title":"J. Biol. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/ncpendmet0786","article-title":"Mechanisms of Disease: Advanced glycation end-products and their receptor in inflammation and diabetes complications","volume":"4","author":"Yan","year":"2008","journal-title":"Nat. Clin. Pract. Endocrinol. Metab."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"E685","DOI":"10.1152\/ajpendo.2001.280.5.E685","article-title":"Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE","volume":"280","author":"Wautier","year":"2001","journal-title":"Am. J. Physiol.-Endocrinol. Metab."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s11010-011-1001-4","article-title":"The association of receptor of advanced glycated end products and inflammatory mediators contributes to endothelial dysfunction in a prospective study of acute kidney injury patients with sepsis","volume":"359","author":"Sadik","year":"2012","journal-title":"Mol. Cell. Biochem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbaexp.2003.08.008","article-title":"Tissue-specific expression patterns of the RAGE receptor and its soluble forms\u2014A result of regulated alternative splicing?","volume":"1630","author":"Schlueter","year":"2003","journal-title":"Biochim. Biophys. Acta BBA-Gene Struct. Expr."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"37525","DOI":"10.1074\/jbc.M111.223438","article-title":"Solution Structure of the Soluble Receptor for Advanced Glycation End Products (sRAGE)","volume":"286","author":"Ikonen","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"35507","DOI":"10.1074\/jbc.M806948200","article-title":"Receptor for Advanced Glycation End Products Is Subjected to Protein Ectodomain Shedding by Metalloproteinases","volume":"283","author":"Zhang","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10059-011-0030-x","article-title":"RAGE: The beneficial and deleterious effects by diverse mechanisms of actions","volume":"31","author":"Han","year":"2011","journal-title":"Mol. Cells"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/2012","article-title":"Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts","volume":"4","author":"Park","year":"1998","journal-title":"Nat. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1515\/bmc-2016-0021","article-title":"Advanced glycation end products mediated cellular and molecular events in the pathology of diabetic nephropathy","volume":"7","author":"Chitra","year":"2016","journal-title":"Biomol. Concepts"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1016\/j.bbamcr.2013.05.024","article-title":"Uptake of advanced glycation end products by proximal tubule epithelial cells via macropinocytosis","volume":"1833","author":"Gallicchio","year":"2013","journal-title":"Biochim. Biophys. Acta BBA-Mol. Cell Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.2337\/diacare.28.10.2465","article-title":"Glycated and Oxidized Protein Degradation Products Are Indicators of Fasting and Postprandial Hyperglycemia in Diabetes","volume":"28","author":"Ahmed","year":"2005","journal-title":"Diabetes Care"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1007\/s00125-005-1810-7","article-title":"Degradation products of proteins damaged by glycation, oxidation and nitration in clinical type 1 diabetes","volume":"48","author":"Ahmed","year":"2005","journal-title":"Diabetologia"},{"key":"ref_29","first-page":"967","article-title":"Effects of glycation process on the macromolecular structure of the glomerular basement membranes and on the glomerular functions in aging and diabetes mellitus","volume":"189","author":"Sternberg","year":"1995","journal-title":"C. R. Seances Soc. Biol. Fil."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1172\/JCI119853","article-title":"Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy","volume":"100","author":"Horie","year":"1997","journal-title":"J. Clin. Investig."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.cellsig.2013.10.002","article-title":"Receptor for advanced glycation end-products promotes premature senescence of proximal tubular epithelial cells via activation of endoplasmic reticulum stress-dependent p21 signaling","volume":"26","author":"Liu","year":"2014","journal-title":"Cell. Signal."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"S241","DOI":"10.1097\/01.ASN.0000077410.66390.0F","article-title":"Reactive Oxygen Species-Regulated Signaling Pathways in Diabetic Nephropathy","volume":"14","author":"Lee","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1111\/dme.13201","article-title":"Methylglyoxal is associated with changes in kidney function among individuals with screen-detected Type 2 diabetes mellitus","volume":"33","author":"Jensen","year":"2016","journal-title":"Diabet. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.2337\/diabetes.54.11.3274","article-title":"Susceptibility to Diabetic Nephropathy Is Related to Dicarbonyl and Oxidative Stress","volume":"54","author":"Beisswenger","year":"2005","journal-title":"Diabetes"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.2337\/dc12-2689","article-title":"Early Progression of Diabetic Nephropathy Correlates With Methylglyoxal-Derived Advanced Glycation End Products","volume":"36","author":"Beisswenger","year":"2013","journal-title":"Diabetes Care"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.2337\/db16-0310","article-title":"Advanced Glycation End Products Predict Loss of Renal Function and Correlate With Lesions of Diabetic Kidney Disease in American Indians With Type 2 Diabetes","volume":"65","author":"Saulnier","year":"2016","journal-title":"Diabetes"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/(SICI)1098-2787(1997)16:6<307::AID-MAS1>3.0.CO;2-L","article-title":"Mass spectrometry in the search for uremic toxins","volume":"16","author":"Niwa","year":"1997","journal-title":"Mass Spectrom. Rev."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1681\/ASN.V781198","article-title":"Accumulation of albumin-linked and free-form pentosidine in the circulation of uremic patients with end-stage renal failure: Renal implications in the pathophysiology of pentosidine","volume":"7","author":"Miyata","year":"1996","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_39","first-page":"1069","article-title":"Factors in human serum interfere with the measurement of advanced glycation endproducts","volume":"44","author":"Dorrian","year":"1998","journal-title":"Cell. Mol. Biol. Noisy-Gd. Fr."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S0002-9440(10)63917-X","article-title":"Advanced Glycation End Products and Receptor for Advanced Glycation End Products in AA Amyloidosis","volume":"162","author":"Mansfeld","year":"2003","journal-title":"Am. J. Pathol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1007\/s00125-004-1451-2","article-title":"Simple non-invasive assessment of advanced glycation endproduct accumulation","volume":"47","author":"Meerwaldt","year":"2004","journal-title":"Diabetologia"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/bmc.491","article-title":"Rapid and simple method for determination of N\u03b5-(carboxymethyl)lysine and N\u03b5-(carboxyethyl)lysine in urine using gas chromatography[sol]mass spectrometry","volume":"19","author":"Futas","year":"2005","journal-title":"Biomed. Chromatogr."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1365-2362.2010.02298.x","article-title":"AGEs\/RAGE in CKD: Irreversible metabolic memory road toward CVD?: AGE\/RAGE AXIS IN CKD","volume":"40","author":"Koyama","year":"2010","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1053\/j.jrn.2006.04.012","article-title":"Advanced Glycation End Products in Renal Failure","volume":"16","author":"Thornalley","year":"2006","journal-title":"J. Ren. Nutr."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.diabet.2009.06.005","article-title":"Advanced glycation end-products: Implications for diabetic and non-diabetic nephropathies","volume":"36","author":"Daroux","year":"2010","journal-title":"Diabetes Metab."},{"key":"ref_46","first-page":"631","article-title":"Increased levels of N(epsilon)-(carboxymethyl)lysine and N(epsilon)-(carboxyethyl)lysine in type 1 diabetic patients with impaired renal function: Correlation with markers of endothelial dysfunction","volume":"19","author":"Teerlink","year":"2004","journal-title":"Nephrol. Dial. Transplant. Off. Publ. Eur. Dial. Transpl. Assoc. -Eur. Ren. Assoc."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.abb.2015.11.003","article-title":"Carboxymethyl lysine induces EMT in podocytes through transcription factor ZEB2: Implications for podocyte depletion and proteinuria in diabetes mellitus","volume":"590","author":"Kumar","year":"2016","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e001203","DOI":"10.1136\/bmjdrc-2020-001203","article-title":"Activation of Notch1 signaling in podocytes by glucose-derived AGEs contributes to proteinuria","volume":"8","author":"Nishad","year":"2020","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"685447","DOI":"10.3389\/fmed.2021.685447","article-title":"Advanced-Glycation End-Products Induce Podocyte Injury and Contribute to Proteinuria","volume":"8","author":"Nishad","year":"2021","journal-title":"Front. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/mnfr.201400643","article-title":"Dietary CML-enriched protein induces functional arterial aging in a RAGE-dependent manner in mice","volume":"59","author":"Grossin","year":"2015","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"126368","DOI":"10.1016\/j.foodchem.2020.126368","article-title":"Maillard reaction products with furan ring, like furosine, cause kidney injury through triggering ferroptosis pathway","volume":"319","author":"Li","year":"2020","journal-title":"Food Chem."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s10068-017-0131-1","article-title":"Furosine induces DNA damage and cell death in selected human cell lines: A strong toxicant to kidney Hek-293 cells","volume":"26","author":"Saeed","year":"2017","journal-title":"Food Sci. Biotechnol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.toxlet.2018.02.018","article-title":"Toxicology studies of furosine in vitro\/in vivo and exploration of the related mechanism","volume":"291","author":"Li","year":"2018","journal-title":"Toxicol. Lett."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1007\/s00726-017-2494-2","article-title":"The role of methionine on metabolism, oxidative stress, and diseases","volume":"49","author":"Li","year":"2017","journal-title":"Amino Acids"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Machowska, A., Sun, J., Qureshi, A.R., Isoyama, N., Leurs, P., Anderstam, B., Heimburger, O., Barany, P., Stenvinkel, P., and Lindholm, B. (2016). Plasma Pentosidine and Its Association with Mortality in Patients with Chronic Kidney Disease. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0163826"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/j.ajkd.2008.06.018","article-title":"Advanced Glycation End Products and Their Circulating Receptors and Level of Kidney Function in Older Community-Dwelling Women","volume":"53","author":"Semba","year":"2009","journal-title":"Am. J. Kidney Dis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1373\/clinchem.2016.264135","article-title":"Cross-Sectional Analysis of AGE-CML, SRAGE, and EsRAGE with Diabetes and Cardiometabolic Risk Factors in a Community-Based Cohort","volume":"63","author":"Loomis","year":"2017","journal-title":"Clin. Chem."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11010-016-2829-4","article-title":"AGEs\/sRAGE, a novel risk factor in the pathogenesis of end-stage renal disease","volume":"423","author":"Prasad","year":"2016","journal-title":"Mol. Cell. Biochem."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000512385","article-title":"Serum and Tissue Levels of Advanced Glycation End Products and Risk of Mortality in Patients on Maintenance Hemodialysis","volume":"52","author":"Jiang","year":"2021","journal-title":"Am. J. Nephrol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1093\/ndt\/gfm050","article-title":"Receptor for advanced glycation end products\u2014Soluble form and gene polymorphisms in chronic haemodialysis patients","volume":"22","author":"Kalousova","year":"2007","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3346\/jkms.2017.32.1.54","article-title":"Associations between Soluble Receptor for Advanced Glycation End Products (SRAGE) and S100A12 (EN-RAGE) with Mortality in Long-Term Hemodialysis Patients","volume":"32","author":"Jung","year":"2017","journal-title":"J. Korean Med. Sci."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/ndt\/gfu259","article-title":"789 Plasma S100A12 and Soluble Receptor of Advanced Glycation End Product Levels and Mortality in Chronic Kidney Disease 790 Stage 5 Patients","volume":"30","author":"Isoyama","year":"2015","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1053\/j.ajkd.2005.12.028","article-title":"Soluble Receptor for Advanced Glycation End Products in Patients With Decreased Renal Function","volume":"47","author":"Zima","year":"2006","journal-title":"Am. J. Kidney Dis."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.diabres.2008.04.013","article-title":"Increased Serum Endogenous Secretory Receptor for Advanced Glycation End-Product (EsRAGE) Levels in Type 2 Diabetic Patients with Decreased Renal Function","volume":"81","author":"Gohda","year":"2008","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3747\/pdi.2014.00121","article-title":"Elevated Circulating S100A12 Associates with Vascular Disease and Worse Clinical Outcome in Peritoneal Dialysis Patients","volume":"36","author":"Isoyama","year":"2016","journal-title":"Perit. Dial. Int. J. Int. Soc. Perit. Dial."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1093\/ndt\/gfl271","article-title":"Myofibroblast Transdifferentiation of Mesothelial Cells Is Mediated by RAGE and Contributes to Peritoneal Fibrosis in Uraemia","volume":"21","author":"Tilton","year":"2006","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3747\/pdi.2009.00031","article-title":"Glucose Degradation Products Result in Cardiovascular Toxicity in a Rat Model of Renal Failure","volume":"30","author":"Kihm","year":"2010","journal-title":"Perit. Dial. Int."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Assiri, A., Kamel, H.F.M., and ALrefai, A. (2018). Critical Appraisal of Advanced Glycation End Products (AGEs) and Circulating Soluble 760 Receptors for Advanced Glycation End Products (SRAGE) as a Predictive Biomarkers for Cardiovascular Disease in 761 Hemodialysis Patients. Med. Sci., 6.","DOI":"10.3390\/medsci6020038"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/ki.1994.262","article-title":"Immunological Quantification of Advanced Glycosylation End-Products in the Serum of Patients on Hemodialysis or CAPD","volume":"46","author":"Papanastasiou","year":"1994","journal-title":"Kidney Int."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0272-6386(00)70189-2","article-title":"Advanced Glycation End Products: A Nephrologist\u2019s Perspective","volume":"35","author":"Raj","year":"2000","journal-title":"Am. J. Kidney Dis."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1254\/jphs.CPJ04005X","article-title":"Roles of the Receptor for Advanced Glycation Endproducts in Diabetes-Induced Vascular Injury","volume":"97","author":"Yonekura","year":"2005","journal-title":"J. Pharmacol. Sci."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.2337\/diacare.28.11.2716","article-title":"Decreased Endogenous Secretory Advanced Glycation End Product Receptor in Type 1 Diabetic Patients","volume":"28","author":"Katakami","year":"2005","journal-title":"Diabetes Care"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.atherosclerosis.2011.07.115","article-title":"Plasma Levels of Soluble Receptor for Advanced Glycation End Products (SRAGE) and Proinflammatory Ligand for RAGE (EN-RAGE) Are Associated with Carotid Atherosclerosis in Patients with Peritoneal Dialysis","volume":"220","author":"Kim","year":"2012","journal-title":"Atherosclerosis"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ijcard.2009.01.008","article-title":"C-Reactive Protein (CRP) up-Regulates Expression of Receptor for Advanced Glycation End Products (RAGE) and Its Inflammatory Ligand EN-RAGE in THP-1 Cells: Inhibitory Effects of Atorvastatin","volume":"142","author":"Mahajan","year":"2010","journal-title":"Int. J. Cardiol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1159\/000226225","article-title":"Advanced Glycation End Products Induce Calcification of Vascular Smooth Muscle Cells through RAGE\/P38 MAPK","volume":"46","author":"Tanikawa","year":"2009","journal-title":"J. Vasc. Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1196\/annals.1433.012","article-title":"A419C (E111A) Polymorphism of the Glyoxalase I Gene and Vascular Complications in Chronic Hemodialysis Patients","volume":"1126","author":"Mestek","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2147\/IJNRD.S40172","article-title":"Diabetic Nephropathy \u2013 Complications and Treatment","volume":"7","author":"Lim","year":"2014","journal-title":"Int. J. Nephrol. Renovasc. Dis."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2337\/diab.37.4.405","article-title":"Epidemiology of Persistent Proteinuria in Type II Diabetes Mellitus: Population-Based Study in Rochester, Minnesota","volume":"37","author":"Ballard","year":"1988","journal-title":"Diabetes"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2337\/dc13-2113","article-title":"Kidney Disease and Related Findings in the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications Study","volume":"37","year":"2014","journal-title":"Diabetes Care"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"UK Prospective Diabetes Study (UKPDS) Group (1998). Intensive Blood-Glucose Control with Sulphonylureas or Insulin Compared with Conventional Treatment and Risk of Complications in Patients with Type 2 Diabetes (UKPDS 33). Lancet, 352, 837\u2013853.","DOI":"10.1016\/S0140-6736(98)07019-6"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S2213-8587(17)30104-3","article-title":"Effects of Intensive Glucose Control on Microvascular Outcomes in Patients with Type 2 Diabetes: A Meta-Analysis of Individual Participant Data from Randomised Controlled Trials","volume":"5","author":"Zoungas","year":"2017","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1093\/ndt\/gfu006","article-title":"Are There Better Alternatives than Haemoglobin A1c to Estimate Glycaemic Control in the Chronic Kidney Disease Population?","volume":"29","author":"Speeckaert","year":"2014","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM199109193251202","article-title":"Advanced Glycosylation End Products in Patients with Diabetic Nephropathy","volume":"325","author":"Makita","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"e002667","DOI":"10.1136\/bmjdrc-2021-002667","article-title":"Plasma Advanced Glycation End Products and the Subsequent Risk of Microvascular Complications in Type 1 Diabetes in the DCCT\/EDIC","volume":"10","author":"Monnier","year":"2022","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"e4421","DOI":"10.7717\/peerj.4421","article-title":"Glycaemic Control in Type 2 Diabetic Patients with Chronic Kidney Disease: The Impacts on Enzymatic Antioxidants and Soluble RAGE","volume":"6","author":"Wong","year":"2018","journal-title":"PeerJ"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"9845175","DOI":"10.1155\/2017\/9845175","article-title":"Increased Levels of SRAGE in Diabetic CKD-G5D Patients: A Potential Protective Mechanism against AGE-Related Upregulation of Fibroblast Growth Factor 23 and Inflammation","volume":"2017","author":"Dozio","year":"2017","journal-title":"Mediat. Inflamm."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.numecd.2021.10.007","article-title":"Skin Autofluorescence Is Associated with Progression of Kidney Disease in Type 2 Diabetes: A Prospective Cohort Study from the Hong Kong Diabetes Biobank","volume":"32","author":"Jin","year":"2022","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"9436","DOI":"10.1073\/pnas.91.20.9436","article-title":"Advanced Glycation End Products Up-Regulate Gene Expression Found in Diabetic Glomerular Disease","volume":"91","author":"Yang","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1097\/HJH.0b013e328335043e","article-title":"Advanced Glycation End-Products Induce Vascular Dysfunction via Resistance to Nitric Oxide and Suppression of Endothelial Nitric Oxide Synthase","volume":"28","author":"Zhang","year":"2010","journal-title":"J. Hypertens."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s13105-013-0291-2","article-title":"Advanced Glycation End Products and Diabetic Nephropathy: A Comparative Study Using Diabetic and Normal Rats with Methylglyoxal-Induced Glycation","volume":"70","author":"Rodrigues","year":"2014","journal-title":"J. Physiol. Biochem."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.numecd.2013.04.004","article-title":"AGEs, Rather than Hyperglycemia, Are Responsible for Microvascular Complications in Diabetes: A \u201cGlycoxidation-Centric\u201d Point of View","volume":"23","author":"Chilelli","year":"2013","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12944-017-0522-6","article-title":"Advanced Glycation End Products (AGEs) Increase Renal Lipid Accumulation: A Pathogenic Factor of Diabetic Nephropathy (DN)","volume":"16","author":"Yuan","year":"2017","journal-title":"Lipids Health Dis."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Brings, S., Fleming, T., Freichel, M., Muckenthaler, M., Herzig, S., and Nawroth, P. (2017). Dicarbonyls and Advanced Glycation End-Products in the Development of Diabetic Complications and Targets for Intervention. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18050984"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1042\/bj3440109","article-title":"Formation of Glyoxal, Methylglyoxal and 3-Deoxyglucosone in the Glycation of Proteins by Glucose","volume":"344","author":"Thornalley","year":"1999","journal-title":"Biochem. J."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/ndt\/gfl564","article-title":"Factors Involved in Vascular Calcification and Atherosclerosis in Maintenance Haemodialysis Patients","volume":"22","author":"Krasniak","year":"2006","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1525-139X.2012.01081.x","article-title":"Role of Advanced Glycation Endproducts and Potential Therapeutic Interventions in Dialysis Patients","volume":"25","author":"Mallipattu","year":"2012","journal-title":"Semin. Dial."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/ndt\/gfu282","article-title":"Association of Plasma Levels of Soluble Receptor for Advanced Glycation End Products and Risk of Kidney Disease: The Atherosclerosis Risk in Communities Study","volume":"30","author":"Rebholz","year":"2015","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2215\/CJN.04291007","article-title":"Endothelial Dysfunction in Patients with Chronic Kidney Disease Results from Advanced Glycation End Products (AGE)-Mediated Inhibition of Endothelial Nitric Oxide Synthase through RAGE Activation","volume":"3","author":"Linden","year":"2008","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1196\/annals.1333.037","article-title":"Accumulation of Advanced Glycation End Products, Measured as Skin Autofluorescence, in Renal Disease","volume":"1043","author":"Hartog","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Gryszczy\u0144ska, B., Budzy\u0144, M., Formanowicz, D., Wanic-Kossowska, M., Formanowicz, P., Majewski, W., Iskra, M., and Kasprzak, M.P. (2020). Selected Atherosclerosis-Related Diseases May Differentially Affect the Relationship between Plasma Advanced Glycation End Products, Receptor SRAGE, and Uric Acid. J. Clin. Med., 9.","DOI":"10.3390\/jcm9051416"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0021-9150(98)00192-0","article-title":"Increased Advanced Glycation End Products in Atherosclerotic Lesions of Patients with End-Stage Renal Disease","volume":"142","author":"Sakata","year":"1999","journal-title":"Atherosclerosis"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/ki.2009.419","article-title":"Circulating Soluble Receptor of Advanced Glycation End Product Inversely Correlates with Atherosclerosis in Patients with Chronic Kidney Disease","volume":"77","author":"Basta","year":"2010","journal-title":"Kidney Int."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.numecd.2010.11.008","article-title":"Circulating Soluble Receptor for Advanced Glycation End Product (SRAGE) and Left Ventricular Hypertrophy in Patients with Chronic Kidney Disease (CKD)","volume":"22","author":"Leonardis","year":"2012","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.2174\/13816128113199990475","article-title":"Role of AGEs-RAGE System in Cardiovascular Disease","volume":"20","author":"Fukami","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1124\/mol.52.1.54","article-title":"Recombinant Advanced Glycation End Product Receptor Pharmacokinetics in Normal and Diabetic Rats","volume":"52","author":"Renard","year":"1997","journal-title":"Mol. Pharmacol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/01.RES.0000065620.39919.20","article-title":"A Breaker of Advanced Glycation End Products Attenuates Diabetes-Induced Myocardial Structural Changes","volume":"92","author":"Candido","year":"2003","journal-title":"Circ. Res."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1097\/BOR.0000000000000642","article-title":"Lupus Nephritis: Challenges and Progress","volume":"31","author":"Davidson","year":"2019","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10157-015-1179-y","article-title":"Lupus Nephritis: An Update","volume":"20","author":"Imran","year":"2016","journal-title":"Clin. Exp. Nephrol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1681\/ASN.V1191656","article-title":"Expression of Advanced Glycation End Products and Their Cellular Receptor RAGE in Diabetic Nephropathy and Nondiabetic Renal Disease","volume":"11","author":"Tanji","year":"2000","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1172\/JCI3042","article-title":"The Myeloperoxidase System of Human Phagocytes Generates N\u03b5-(Carboxymethyl)Lysine on Proteins: A Mechanism for Producing Advanced Glycation End Products at Sites of Inflammation","volume":"104","author":"Anderson","year":"1999","journal-title":"J. Clin. Investig."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1177\/0961203314559631","article-title":"Members of the Receptor for Advanced Glycation End Products Axis as Potential Therapeutic Targets in Patients with Lupus Nephritis","volume":"24","author":"Yu","year":"2015","journal-title":"Lupus"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"940","DOI":"10.2174\/092986709787581888","article-title":"Soluble Forms of RAGE in Human Diseases: Clinical and Therapeutical Implications","volume":"16","author":"Santilli","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1177\/0961203312444495","article-title":"Receptor for Advanced Glycation End Products (RAGE) Polymorphisms Are Associated with Systemic Lupus Erythematosus and Disease Severity in Lupus Nephritis","volume":"21","author":"Martens","year":"2012","journal-title":"Lupus"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/MNH.0b013e328336eafd","article-title":"Membranous Glomerulopathy: The Evolving Story","volume":"19","author":"Ronco","year":"2010","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/ndt\/15.3.355","article-title":"Glycoxidative Modification of AA Amyloid Deposits in Renal Tissue","volume":"15","author":"Uesugi","year":"2000","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1046\/j.1523-1755.1999.00302.x","article-title":"Alterations in Nonenzymatic Biochemistry in Uremia: Origin and Significance of \u201cCarbonyl Stress\u201d in Long-Term Uremic Complications","volume":"55","author":"Miyata","year":"1999","journal-title":"Kidney Int."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.2337\/diab.46.9.1481","article-title":"Advanced Glycation End Product-Induced Activation of NF-\u039aB Is Suppressed by \u03b1-Lipoic Acid in Cultured Endothelial Cells","volume":"46","author":"Bierhaus","year":"1997","journal-title":"Diabetes"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"17810","DOI":"10.1074\/jbc.272.28.17810","article-title":"Activation of the Receptor for Advanced Glycation End Products Triggers a P21 -Dependent Mitogen-Activated Protein Kinase Pathway Regulated by Oxidant Stress","volume":"272","author":"Lander","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Greven, W.L., Smit, J.M., Rommes, J.H., and Spronk, P.E. (2010). Accumulation of Advanced Glycation End (AGEs) Products in Intensive Care Patients: An Observational, Prospective Study. BMC Clin. Pathol., 10.","DOI":"10.1186\/1472-6890-10-4"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jss.2007.07.014","article-title":"SRAGE Is Elevated in Septic Patients and Associated With Patients Outcome","volume":"147","author":"Bopp","year":"2008","journal-title":"J. Surg. Res."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/SHK.0000000000000278","article-title":"Soluble RAGE and the RAGE Ligands HMGB1 and S100A12 in Critical Illness: Impact of Glycemic Control with Insulin and Relation with Clinical Outcome","volume":"43","author":"Ingels","year":"2015","journal-title":"Shock"},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Zakiyanov, O., Kriha, V., Vachek, J., Zima, T., Tesar, V., and Kalousova, M. (2013). Placental Growth Factor, Pregnancy-Associated Plasma Protein-A, Soluble Receptor for Advanced Glycation End Products, Extracellular Newly Identified Receptor for Receptor for Advanced Glycation End Products Binding Protein and High Mobility Group Box 1 Levels in Patients with Acute Kidney Injury: A Cross Sectional Study. BMC Nephrol., 14.","DOI":"10.1186\/1471-2369-14-245"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s004670100038","article-title":"Plasma Levels of Advanced Glycation End Products in Children with Renal Disease","volume":"16","author":"Heidland","year":"2001","journal-title":"Pediatr. Nephrol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.2215\/CJN.00540119","article-title":"Circulating Advanced Glycation Endproducts and Long-Term Risk of Cardiovascular Mortality in Kidney Transplant Recipients","volume":"14","author":"Sotomayor","year":"2019","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1093\/ndt\/gfl132","article-title":"Risk Factors for Chronic Transplant Dysfunction and Cardiovascular Disease Are Related to Accumulation of Advanced Glycation End-Products in Renal Transplant Recipients","volume":"21","author":"Hartog","year":"2006","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/ki.1993.58","article-title":"Effects of Kidney or Kidney-Pancreas Transplantation on Plasma Pentosidine","volume":"43","author":"Hricik","year":"1993","journal-title":"Kidney Int."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"2189582","DOI":"10.1155\/2016\/2189582","article-title":"Advanced Glycation End Products Evolution after Pancreas-Kidney Transplantation: Plasmatic and Cutaneous Assessments","volume":"2016","author":"Martins","year":"2016","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1046\/j.1523-1755.2002.00115.x","article-title":"AGEs Bind to Mesothelial Cells via RAGE and Stimulate VCAM-1 Expression","volume":"61","author":"Boulanger","year":"2002","journal-title":"Kidney Int."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1111\/j.1523-1755.2004.00961.x","article-title":"In Vitro Evidence for Immune Activating Effect of Specific AGE Structures Retained in Uremia","volume":"66","author":"Glorieux","year":"2004","journal-title":"Kidney Int."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/01.tp.0000280556.16275.2a","article-title":"Low Levels of SRAGE Are Associated With Increased Risk for Mortality in Renal Transplant Recipients","volume":"84","author":"Gross","year":"2007","journal-title":"Transplantation"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.str.2011.02.013","article-title":"Advanced Glycation End Product Recognition by the Receptor for AGEs","volume":"19","author":"Xue","year":"2011","journal-title":"Structure"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1001\/jamadermatol.2013.836","article-title":"Influence of Cyclosporin and Prednisolone on RAGE, S100A8\/A9, and NF\u03baB Expression in Human Keratinocytes","volume":"149","author":"Djerbi","year":"2013","journal-title":"JAMA Dermatol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.cardiores.2004.05.001","article-title":"Advanced Glycation End Products and Vascular Inflammation: Implications for Accelerated Atherosclerosis in Diabetes","volume":"63","author":"Basta","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1053\/j.ajkd.2004.02.008","article-title":"Advanced Glycation End Products in Kidney Transplant Patients: A Putative Role in the Development of Chronic Renal Transplant Dysfunction","volume":"43","author":"Hartog","year":"2004","journal-title":"Am. J. Kidney Dis."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"946","DOI":"10.2174\/138161208784139710","article-title":"Role of AGEs in Diabetic Nephropathy","volume":"14","author":"Fukami","year":"2008","journal-title":"Curr. Pham. Des."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"188","DOI":"10.4093\/dmj.2017.0105","article-title":"The Role of Advanced Glycation End Products in Diabetic Vascular Complications","volume":"42","author":"Rhee","year":"2018","journal-title":"Diabetes Metab. J."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/7\/3439\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:41:02Z","timestamp":1760136062000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/7\/3439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,22]]},"references-count":136,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,4]]}},"alternative-id":["ijms23073439"],"URL":"https:\/\/doi.org\/10.3390\/ijms23073439","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,22]]}}}